Daria Pagliara

Medicine & Life Sciences

1. Hematopoietic Stem Cell Transplantation 100%
2. T-Lymphocytes 72%
3. Graft vs Host Disease 47%
4. Leukemia 40%
5. B-Lymphocytes 35%
6. Child 32%
7. Unrelated Donors 30%
8. Transplants 30%
9. Pediatrics 27%
10. Tissue Donors 25%
11. Natural Killer Cells 24%
12. Stem Cell Transplantation 22%
13. Chimeric Antigen Receptors 20%
14. Fanconi Anemia 20%
15. Human Herpesvirus 4 19%
16. Incidence 16%
17. Zoledronic Acid 15%
18. Thomsen-Friedenreich antibodies 14%
19. Globulins 13%
20. Busulfan 13%
21. Whole-Body Irradiation 12%
22. Cytotoxic T-Lymphocytes 12%
23. Hematologic Neoplasms 11%
24. Cell- and Tissue-Based Therapy 11%
25. Neuroblastoma 10%
26. Hematopoietic Stem Cells 10%
27. Neoplasms 10%
28. Regulatory T-Lymphocytes 10%
29. Cytokines 9%
30. Thalassemia 9%
31. Interleukin-7 9%
32. Mesenchymal Stem Cells 9%
33. Interleukin-15 9%
34. treosulfan 8%
35. Mutation 8%
36. Fanconi Anemia Complementation Group Proteins 8%
37. Colonic Pseudo-Obstruction 8%
38. Haploidentical Transplantation 8%
39. Juvenile Myelomonocytic Leukemia 8%
40. Cytomegalovirus 7%
41. Survival 7%
42. Precursor Cell Lymphoblastic Leukemia-Lymphoma 7%
43. Rabbits 7%
44. Lymphoproliferative Disorders 7%
45. Recurrence 7%
46. CTLA-4 Antigen 7%
47. Genes 7%
48. Lymphocytes 6%
49. Retrospective Studies 6%
50. Transplantation 6%